含牛脂胺草甘膦制剂急性中毒严重程度更高
该研究为法国毒物控制中心2008年1月1日至2014年12月12日的回顾性研究,比较含牛脂胺(TA)与不含牛脂胺(NTA)的草甘膦制剂口服中毒的严重程度。共登记1362例草甘膦制剂摄入,其中429例为有症状的急性摄入病例:TA组235例、NTA组105例、未知辅料组89例。TA组严重病例多于NTA组(p=0.037),TA组严重呼吸道症状也更频繁报告。作者认为表面活性剂POEA而非其他辅料导致更严重症状,其刺激性及表面活性可能引起吸入性肺炎,从而解释严重草甘膦中毒合并呼吸衰竭。
要点
- 法国毒物中心7年回顾性研究:429例有症状的草甘膦制剂口服中毒中,TA组235例、NTA组105例、未知辅料组89例。
- 含牛脂胺(TA)组严重病例多于不含牛脂胺(NTA)组(p=0.037)。
- TA组严重呼吸道症状报告频率高于NTA组。
- 作者认为POEA而非其他辅料导致更严重症状,其刺激性和表面活性可能引起吸入性肺炎,解释严重草甘膦中毒合并呼吸衰竭。
适用人群与场景
- 2008年1月1日至2014年12月12日向法国毒物控制中心报告的草甘膦制剂口服暴露病例。
- 有症状的急性草甘膦制剂摄入病例(429例)纳入严重程度比较。
红旗征与不能漏的情况
- 含牛脂胺草甘膦制剂口服中毒者出现严重呼吸道症状,作者认为POEA表面活性可能引起吸入性肺炎,是严重草甘膦中毒合并呼吸衰竭的合理解释。
研究设计与关键结果
- 研究类型:回顾性研究;数据来源:法国毒物控制中心2008年1月1日至2014年12月12日报告病例。
- 共登记1362例草甘膦制剂摄入,其中429例为有症状的急性摄入病例。
- 429例中,235例暴露于含牛脂胺制剂(TA),105例暴露于不含牛脂胺制剂(NTA),89例暴露于辅料未知的草甘膦制剂。
- TA组严重病例多于NTA组(p=0.037)。
- TA组严重呼吸道症状报告频率高于NTA组。
证据类型、等级与局限
- 证据类型:回顾性研究,基于法国毒物控制中心国家产品与成分数据库及中毒病例数据库。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为POEA而非其他辅料导致草甘膦制剂口服中毒患者症状更严重。
- 作者认为POEA的刺激性和表面活性可能引起吸入性肺炎,是严重草甘膦中毒合并呼吸衰竭的合理解释。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Context: During the re-approval process of glyphosate in Europe, it was mentioned that glyphosate-based products (GBF) were more toxic than glyphosate alone. This phenomenon was attributed to the surfactants and among them, polyethoxylated tallowamine (POEA) has been suspected to significantly contribute to the toxicity of glyphosate products. In animal data acute oral toxicity of POEA has been suggested to be greater than glyphosate toxicity in animal studies. There are no data, however, comparing the clinical signs and severity of acute human poisoning with tallowamine-containing GBF (TA) and non-tallowamine-containing GBF (NTA). The aim of this study was to compare the severity of oral poisoning between TA and NTA cases, reported to the French Poison Control Centres (PCC) over 7 years.Methods: This is a retrospective study of cases of oral exposure to GBF reported to French PCCs between January 1st, 2008 and December 12th, 2014. The formulation of every GBF was reviewed using the PCC national database of products and compositions, to identify cases involving TA, NTA, or GBF with unknown co-formulants.Results: Between 2008 and 2014, 1362 cases of GBF ingestion were registered in the PCC national database of poisoning cases. Among them, 429 were symptomatic acute cases of ingestion of GBF. There were 235 exposures to TA, 105 to NTA, and 89 to unknown GBF. There were more severe cases in the TA group than in the NTA group (p = 0.037).Discussion: The present study shows that POEA rather than other co-formulants leads to more severe symptoms in those patients ingesting GBF. The acute toxicity of POEA might be explained by its irritating properties; in experimental studies, it caused skin irritation and severe eye and mucous membranes irritation.Conclusion: In this study, severe respiratory symptoms were also more frequently reported in the TA group. The surfactant properties of POEA are likely to cause aspiration pneumonitis which is a plausible explanation for the respiratory failure complicating severe GBF poisoning cases.
参考来源
- Langrand J, Blanc-Brisset I, Boucaud-Maitre D, et al. Increased severity associated with tallowamine in acute glyphosate poisoning. Clin Toxicol (Phila). 2019. PMID: 31169038. doi:10.1080/15563650.2019.1623406
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。